{"version":"1.0","provider_name":"DEV R-Biopharm AG","provider_url":"https:\/\/dev.r-biopharm.com\/fr\/","author_name":"niclas","author_url":"https:\/\/dev.r-biopharm.com\/fr\/author\/niclas\/","title":"Suivi et ma\u00eetrise de la contamination - DEV R-Biopharm AG","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"phtkzW1YHM\"><a href=\"https:\/\/dev.r-biopharm.com\/fr\/suivi-et-maitrise-de-la-contamination\/\">Suivi et ma\u00eetrise de la contamination<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/dev.r-biopharm.com\/fr\/suivi-et-maitrise-de-la-contamination\/embed\/#?secret=phtkzW1YHM\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Suivi et ma\u00eetrise de la contamination\u00a0\u00bb &#8212; DEV R-Biopharm AG\" data-secret=\"phtkzW1YHM\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/dev.r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg","thumbnail_width":1667,"thumbnail_height":1667,"description":"[vc_row][vc_column][vc_single_image image=\u00a0\u00bb7456&Prime; img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][vc_column_text css=\u00a0\u00bb.vc_custom_1654777676108{margin-bottom: 0px !important;}\u00a0\u00bb]Darmstadt, Allemagne, 1er juin 2022 \u2013 R-Biopharm AG, une soci\u00e9t\u00e9 leader de biotechnologies d\u2019envergure mondiale bas\u00e9e en Allemagne, commercialisera bient\u00f4t un test de d\u00e9pistage du virus de la variole du singe. Ce test de PCR en temps r\u00e9el, con\u00e7u \u00e0 des fins de recherche, devrait contribuer au suivi et [&hellip;]"}